Lifileucel: FDA-approved T-cell therapy for melanoma

被引：4

作者：

Kwong, Mei Li M. ^{[1
]}

Yang, James C. ^{[1
]}

机构：

[1] NCI, Surg Branch, NIH, Bethesda, MD 20814 USA

来源：

ONCOLOGIST | 2024年 / 29卷 / 08期

关键词：

TUMOR-INFILTRATING LYMPHOCYTES; METASTATIC MELANOMA; ADOPTIVE TRANSFER; IMMUNOTHERAPY; INTERLEUKIN-2; EFFICACY; CANCER;

D O I：

10.1093/oncolo/oyae136

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

This commentary reports on the history of tumor-infiltrating lymphocytes (TIL) for adoptive cell therapy and where TIL fits into the treatment options for metastatic melanoma.

引用

页码：648 / 650

页数：3

共 18 条

[1] Adoptive Transfer of Tumor-Infiltrating Lymphocytes in Patients with Metastatic Melanoma: Intent-to-Treat Analysis and Efficacy after Failure to Prior Immunotherapies
Besser, Michal J.
Shapira-Frommer, Ronnie
Itzhaki, Orit
Treves, Avraham J.
Zippel, Douglas B.
Levy, Daphna
Kubi, Adva
Shoshani, Noa
Zikich, Dragoslav
Ohayon, Yaara
Ohayon, Daniel
Shalmon, Bruria
Markel, Gal
Yerushalmi, Ronit
Apter, Sara
Ben-Nun, Alon
Ben-Ami, Eytan
Shimoni, Avichai
Nagler, Arnon
Schachter, Jacob
[J]. CLINICAL CANCER RESEARCH, 2013, 19 (17) : 4792 - 4800
[2] Efficacy and safety of lifileucel, a one-time autologous tumor-infiltrating lymphocyte (TIL) cell therapy, in patients with advanced melanoma after progression on immune checkpoint inhibitors and targeted therapies: pooled analysis of consecutive cohorts of the C-144-01 study
Chesney, Jason
Lewis, Karl D.
Kluger, Harriet
Hamid, Omid
Whitman, Eric
Thomas, Sajeve
Wermke, Martin
Cusnir, Mike
Domingo-Musibay, Evidio
Phan, Giao Q.
Kirkwood, John M.
Hassel, Jessica C.
Orloff, Marlana
Larkin, James
Weber, Jeffrey
Furness, Andrew J. S.
Khushalani, Nikhil, I
Medina, Theresa
Egger, Michael E.
Finckenstein, Friedrich Graf
Jagasia, Madan
Hari, Parameswaran
Sulur, Giri
Shi, Wen
Wu, Xiao
Sarnaik, Amod
[J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (12)
[3] A Pilot Trial of the Combination of Vemurafenib with Adoptive Cell Therapy in Patients with Metastatic Melanoma
Deniger, Drew C.
Kwong, Mei Li M.
Pasetto, Anna
Dudley, Mark E.
Wunderlich, John R.
Langhan, Michelle M.
Lee, Chyi-Chia Richard
Rosenberg, Steven A.
[J]. CLINICAL CANCER RESEARCH, 2017, 23 (02) : 351 - 362
[4] Adoptive Cell Therapy for Patients With Metastatic Melanoma: Evaluation of Intensive Myeloablative Chemoradiation Preparative Regimens
Dudley, Mark E.
Yang, James C.
Sherry, Richard
Hughes, Marybeth S.
Royal, Richard
Kammula, Udai
Robbins, Paul F.
Huang, JianPing
Citrin, Deborah E.
Leitman, Susan F.
Wunderlich, John
Restifo, Nicholas P.
Thomasian, Armen
Downey, Stephanie G.
Smith, Franz O.
Klapper, Jacob
Morton, Kathleen
Laurencot, Carolyn
White, Donald E.
Rosenberg, Steven A.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (32) : 5233 - 5239
[5] FDA, 2024, FDA approves first cellular therapy to treat patients with unresectable or metastatic melanoma
[6] Randomized, Prospective Evaluation Comparing Intensity of Lymphodepletion Before Adoptive Transfer of Tumor-Infiltrating Lymphocytes for Patients With Metastatic Melanoma
Goff, Stephanie L.
Dudley, Mark E.
Citrin, Deborah E.
Somerville, Robert P.
Wunderlich, John R.
Danforth, David N.
Zlott, Daniel A.
Yang, James C.
Sherry, Richard M.
Kammula, Udai S.
Klebanoff, Christopher A.
Hughes, Marybeth S.
Restifo, Nicholas P.
Langhan, Michelle M.
Shelton, Thomas E.
Lu, Lily
Kwong, Mei Li M.
Ilyas, Sadia
Klemen, Nicholas D.
Payabyab, Eden C.
Morton, Kathleen E.
Toomey, Mary Ann
Steinberg, Seth M.
White, Donald E.
Rosenberg, Steven A.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (20) : 2389 - U145
[7] Efficacy of Adoptive Cell Transfer of Tumor-infiltrating Lymphocytes After Lymphopenia Induction for Metastatic Melanoma
Pilon-Thomas, Shari
Kuhn, Lisa
Ellwanger, Sabine
Janssen, William
Royster, Erica
Marzban, Suroosh
Kudchadkar, Ragini
Zager, Jonathan
Gibney, Geoffrey
Sondak, Vernon K.
Weber, Jeffrey
Mule, James J.
Sarnaik, Amod A.
[J]. JOURNAL OF IMMUNOTHERAPY, 2012, 35 (08) : 615 - 620
[8] Mining exomic sequencing data to identify mutated antigens recognized by adoptively transferred tumor-reactive T cells
Robbins, Paul F.
Lu, Yong-Chen
El-Gamil, Mona
Li, Yong F.
Gross, Colin
Gartner, Jared
Lin, Jimmy C.
Teer, Jamie K.
Cliften, Paul
Tycksen, Eric
Samuels, Yardena
Rosenberg, Steven A.
[J]. NATURE MEDICINE, 2013, 19 (06) : 747 - +
[9] Tumor-Infiltrating Lymphocyte Therapy or Ipilimumab in Advanced Melanoma
Rohaan, Maartje W.
Borch, Troels H.
van den Berg, Joost H.
Met, Ozcan
Kessels, Rob
Geukes Foppen, Marnix H.
Stoltenborg Granhoj, Joachim
Nuijen, Bastiaan
Nijenhuis, Cynthia
Jedema, Inge
van Zon, Maaike
Scheij, Saskia
Beijnen, Jos H.
Hansen, Marten
Voermans, Carlijn
Noringriis, Inge M.
Monberg, Tine J.
Holmstroem, Rikke B.
Wever, Lidwina D. V.
van Dijk, Marloes
Grijpink-Ongering, Lindsay G.
Valkenet, Ludy H. M.
Torres Acosta, Alejandro
Karger, Matthias
Borgers, Jessica S. W.
ten Ham, Renske M. T.
Retel, Valesca P.
van Harten, Wim H.
Lalezari, Ferry
van Tinteren, Harm
van der Veldt, Astrid A. M.
Hospers, Geke A. P.
Stevense-den Boer, Marion A. M.
Suijkerbuijk, Karijn P. M.
Aarts, Maureen J. B.
Piersma, Djura
van den Eertwegh, Alfons J. M.
de Groot, Jan-Willem B.
Vreugdenhil, Gerard
Kapiteijn, Ellen
Boers-Sonderen, Marye J.
Fiets, W. Edward
van den Berkmortel, Franchette W. P. J.
Ellebaek, Eva
Hoelmich, Lisbet R.
van Akkooi, Alexander C. J.
van Houdt, Winan J.
Wouters, Michel W. J. M.
van Thienen, Johannes V.
Blank, Christian U.
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (23) : 2113 - 2125
[10] BIOLOGICAL-ACTIVITY OF RECOMBINANT HUMAN INTERLEUKIN-2 PRODUCED IN ESCHERICHIA-COLI
ROSENBERG, SA
GRIMM, EA
MCGROGAN, M
DOYLE, M
KAWASAKI, E
KOTHS, K
MARK, DF
[J]. SCIENCE, 1984, 223 (4643) : 1412 - 1414

← 1 2 →